Trending...
- Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
- Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
- LiteracyNation's 3rd Annual Indie Author Book Fair
PHILADELPHIA--(BUSINESS WIRE)--Audacy announced a multiplatform partnership with mental health innovator Genomind. This breakthrough partnership taps into Audacy's influencers and Genomind's personalized genetic insights to bring mental health conversations into the mainstream.
As part of the partnership, Audacy will leverage the deep local connection of 15 stations across eight markets – Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington D.C. – to promote Genomind's new Mental Health Map™, the first and only consumer DNA test to offer a concise, easy-to-navigate blueprint of your genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior, and eating behavior.
Audacy and Genomind align in shared commitment to end the stigma surrounding mental health. Audacy's trusted voices and influencers will serve as ambassadors for the campaign – sharing their first hand experiences, using the Mental Health Map to learn more about their genetic makeup and predispositions toward mental health and wellness traits. Audacy is also among the first to provide Genomind as an employee benefit to help drive more engagement and action in mental health and wellness.
"Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we're excited to further activate our commitment through this partnership with Genomind," said Sarah Harris, Vice President, Social Impact, Audacy. "We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind's mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health."
More on The PennZone
"Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness," said Kip Olmstead, President, Genomind. "Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy's leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner."
Genomind will also serve as the sponsor for Audacy's "I'm Listening Daily Capsules," 60-second daily public service announcements as part of the company's yearlong "I'm Listening" mental health initiative. Genomind will also serve as the presenting sponsor of Audacy's annual "I'm Listening" broadast, a live national program that brings together artists, athletes and medical specialists every September to remind listeners it's okay to not be okay, raise awareness and end the stigma of talking about mental health.
Audacy is committed to supporting the health and success of the communities that are the heart of its business. "I'm Listening" is a part of Audacy Serves, the Company's social impact platform that raises awareness of social issues and brings communities together for good. Audacy unites with its listeners and brands to support sound communities through several pillars of impact: mental health and anti-bullying, veterans and service members, children's health, the environment, civic education, and diversity, equity and inclusion.
More on The PennZone
About Audacy
Audacy, Inc. (NYSE: AUD) is a scaled, multi-platform audio content and entertainment company with the country's best radio broadcasting group, a leader in virtually every segment of audio, and America's #1 creator of original, premium audio. Audacy engages over 170 million consumers each month, bringing people together around the news, sports, podcasts and music that matter to them. Learn more at www.audacyinc.com, Facebook (Audacy Corp) and Twitter (@AudacyCorp).
About Genomind
Genomind is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, clinical collaboration and consultation, state-of-the-art digital tools and telemental health enabling services, Genomind is empowering a new standard of care. Its flagship product, Genomind® Professional PGx Express™, is the most comprehensive pharmacogenetic testing service helping medical professionals personalize patients' mental health treatment. The Company also recently launched GenMed✓ Pro™ – Genomind's Smarter Precision Gene-Drug Interaction Software. This advanced medication management software was designed to help health professionals make safer prescribing decisions with speed and precision. In 2020 the company introduced the Genomind Mental Health Map™ – a breakthrough direct-to-consumer test that enables a new and better understanding of the biological basis of mental wellness, coupled with personalized actionable guidance to help people improve health and wellness. Learn more at https://www.genomind.com/.
As part of the partnership, Audacy will leverage the deep local connection of 15 stations across eight markets – Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington D.C. – to promote Genomind's new Mental Health Map™, the first and only consumer DNA test to offer a concise, easy-to-navigate blueprint of your genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior, and eating behavior.
Audacy and Genomind align in shared commitment to end the stigma surrounding mental health. Audacy's trusted voices and influencers will serve as ambassadors for the campaign – sharing their first hand experiences, using the Mental Health Map to learn more about their genetic makeup and predispositions toward mental health and wellness traits. Audacy is also among the first to provide Genomind as an employee benefit to help drive more engagement and action in mental health and wellness.
"Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we're excited to further activate our commitment through this partnership with Genomind," said Sarah Harris, Vice President, Social Impact, Audacy. "We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind's mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health."
More on The PennZone
- Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
- Chuckie F. Mahoney Memorial Foundation Awards Nearly $40,000 in School Grants
- OPUS Global Data Solutions Launches Food Trader Plus, Bringing Operational Control and Deal-Level Profit Visibility to Food Brokers
- Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
- Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
"Genomind works to help all of us understand our personal mental health wiring and give people new insights and tools to manage and promote personalized mental health and wellness," said Kip Olmstead, President, Genomind. "Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started. Audacy's leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner."
Genomind will also serve as the sponsor for Audacy's "I'm Listening Daily Capsules," 60-second daily public service announcements as part of the company's yearlong "I'm Listening" mental health initiative. Genomind will also serve as the presenting sponsor of Audacy's annual "I'm Listening" broadast, a live national program that brings together artists, athletes and medical specialists every September to remind listeners it's okay to not be okay, raise awareness and end the stigma of talking about mental health.
Audacy is committed to supporting the health and success of the communities that are the heart of its business. "I'm Listening" is a part of Audacy Serves, the Company's social impact platform that raises awareness of social issues and brings communities together for good. Audacy unites with its listeners and brands to support sound communities through several pillars of impact: mental health and anti-bullying, veterans and service members, children's health, the environment, civic education, and diversity, equity and inclusion.
More on The PennZone
- LATO AI Software Innovations Expedite Inspections & Repair of Parking Lots for The Pavement Group
- Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
- Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
- Contracting Resources Group Named to Inc. 5000 for the Ninth Time
- Nola Blue Records to Release John Németh's Illinois Central in March 2027
About Audacy
Audacy, Inc. (NYSE: AUD) is a scaled, multi-platform audio content and entertainment company with the country's best radio broadcasting group, a leader in virtually every segment of audio, and America's #1 creator of original, premium audio. Audacy engages over 170 million consumers each month, bringing people together around the news, sports, podcasts and music that matter to them. Learn more at www.audacyinc.com, Facebook (Audacy Corp) and Twitter (@AudacyCorp).
About Genomind
Genomind is a leading precision mental health company singularly focused on filling the innovation gap in mental health care through novel, genetics-based tools. Supported by a world-class genetics lab, a unique heritage of clinical mental health expertise, clinical collaboration and consultation, state-of-the-art digital tools and telemental health enabling services, Genomind is empowering a new standard of care. Its flagship product, Genomind® Professional PGx Express™, is the most comprehensive pharmacogenetic testing service helping medical professionals personalize patients' mental health treatment. The Company also recently launched GenMed✓ Pro™ – Genomind's Smarter Precision Gene-Drug Interaction Software. This advanced medication management software was designed to help health professionals make safer prescribing decisions with speed and precision. In 2020 the company introduced the Genomind Mental Health Map™ – a breakthrough direct-to-consumer test that enables a new and better understanding of the biological basis of mental wellness, coupled with personalized actionable guidance to help people improve health and wellness. Learn more at https://www.genomind.com/.
0 Comments
Latest on The PennZone
- LiteracyNation's 3rd Annual Indie Author Book Fair
- FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
- Insurance for Braces Helps Make Treatment More Manageable for Pennsylvania Families
- Black Ribbon Productions Launches With Fearless 2026 Horror Slate
- Actor Dominic Pace Returns to Television and Film
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
- Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
- Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
- Meals on Wheels of the Greater Lehigh Valley Awarded $50,000 Grant from Harry C. Trexler Trust
- RPR Promotes Emily Line to Chief Strategy Officer and Janine Sieja to Chief Product Officer
- Kellyn Hosts Fourth Lehigh Valley Lifestyle Medicine Symposium
- Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
- Lauren Merrell, Dale Sorensen Real Estate, announces price improvement for an extraordinary island retreat
- Portalz Publishes FES World First Architecture Introducing a New Cryptographic Platform
- Racquet Club of Philadelphia appoints Michael J. Sofia as new General Manager
- Cellofest Brings Free Cello Concerts and Community Events to Bethany Beach August 5–16
- Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc